Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Claude Hofmann

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Thyroid : Official Journal of the American Thyroid Association|May 19, 2025
Reimagining the Therapeutic Approach for Anaplastic Thyroid Cancer: The Roadmap to a CureMaria E Cabanillas, Neal Akhave, Victoria Banuchi, et al.
JCO Precision Oncology|February 9, 2022
Circulating <i>BRAF</i> V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid CarcinomaPriyanka C Iyer, Gilbert J Cote, Tao Hai, et al.
Cancer Research|August 19, 2015
Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical CarcinomaLiem M Phan, Enrique Fuentes-Mattei, Weixin Wu, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Activating <i>RET</i> Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid CancerRozita Bagheri-Yarmand, Gabriel M Pagnotti, Joseph L Kidd, et al.
The Journal of Clinical Endocrinology and Metabolism|June 13, 2021
A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid CarcinomaYing C Henderson, Abdallah S R Mohamed, Anastasios Maniakas, et al.
The Journal of Clinical Endocrinology and Metabolism|June 19, 2021
Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic DiversityAnastasios Maniakas, Ying C Henderson, Hu Hei, et al.
Cancers|October 13, 2021
<i>RAC1</i> Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer PatientRozita Bagheri-Yarmand, Naifa L Busaidy, Elena McBeath, et al.
Thyroid : Official Journal of the American Thyroid Association|February 10, 2023
Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAF<sup>V600E</sup> Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort StudyXiao Zhao, Jennifer Rui Wang, Ramona Dadu, et al.
The Journal of Clinical Endocrinology and Metabolism|June 26, 2025
Characterization of advanced RAS-driven follicular-derived thyroid cancers and review of future therapeutic avenuesSarah Hamidi, Anastasios Maniakas, Neal S Akhave, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Role of the ETV5/p38 signaling axis in aggressive thyroid cancer cellsJerry H Houl, Rozita Bagheri-Yarmand, Muthusamy Kunnimalaiyaan, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Thyroid : Official Journal of the American Thyroid Association|May 19, 2025
Reimagining the Therapeutic Approach for Anaplastic Thyroid Cancer: The Roadmap to a CureMaria E Cabanillas, Neal Akhave, Victoria Banuchi, et al.
JCO Precision Oncology|February 9, 2022
Circulating <i>BRAF</i> V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid CarcinomaPriyanka C Iyer, Gilbert J Cote, Tao Hai, et al.
Cancer Research|August 19, 2015
Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical CarcinomaLiem M Phan, Enrique Fuentes-Mattei, Weixin Wu, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Activating <i>RET</i> Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid CancerRozita Bagheri-Yarmand, Gabriel M Pagnotti, Joseph L Kidd, et al.
The Journal of Clinical Endocrinology and Metabolism|June 13, 2021
A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid CarcinomaYing C Henderson, Abdallah S R Mohamed, Anastasios Maniakas, et al.
The Journal of Clinical Endocrinology and Metabolism|June 19, 2021
Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic DiversityAnastasios Maniakas, Ying C Henderson, Hu Hei, et al.
Cancers|October 13, 2021
<i>RAC1</i> Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer PatientRozita Bagheri-Yarmand, Naifa L Busaidy, Elena McBeath, et al.
Thyroid : Official Journal of the American Thyroid Association|February 10, 2023
Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAF<sup>V600E</sup> Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort StudyXiao Zhao, Jennifer Rui Wang, Ramona Dadu, et al.
The Journal of Clinical Endocrinology and Metabolism|June 26, 2025
Characterization of advanced RAS-driven follicular-derived thyroid cancers and review of future therapeutic avenuesSarah Hamidi, Anastasios Maniakas, Neal S Akhave, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Role of the ETV5/p38 signaling axis in aggressive thyroid cancer cellsJerry H Houl, Rozita Bagheri-Yarmand, Muthusamy Kunnimalaiyaan, et al.
Pageof 8